KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Accumulated Expenses: 2013-2024

Historic Accumulated Expenses for Xenon Pharmaceuticals (XENE) over the last 11 years, with Dec 2024 value amounting to $12.1 million.

  • Xenon Pharmaceuticals' Accumulated Expenses rose 95.75% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year increase of 95.75%. This contributed to the annual value of $12.1 million for FY2024, which is 36.68% up from last year.
  • As of FY2024, Xenon Pharmaceuticals' Accumulated Expenses stood at $12.1 million, which was up 36.68% from $8.8 million recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Accumulated Expenses registered a high of $12.1 million during FY2024, and its lowest value of $2.9 million during FY2020.
  • Moreover, its 3-year median value for Accumulated Expenses was $8.8 million (2023), whereas its average is $8.9 million.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Accumulated Expenses skyrocketed by 107.76% in 2021, and later fell by 1.97% in 2022.
  • Xenon Pharmaceuticals' Accumulated Expenses (Yearly) stood at $2.9 million in 2020, then skyrocketed by 107.76% to $5.9 million in 2021, then dropped by 1.97% to $5.8 million in 2022, then soared by 51.54% to $8.8 million in 2023, then soared by 36.68% to $12.1 million in 2024.